By Karlee Weinmann ( September 19, 2013, 2:19 PM EDT) -- The top executive at Swiss drugmaker Roche Holding AG doused reports that his company was lining up financing for a BioMarin Pharmaceutical Inc. takeover play, according to a Thursday report from Bloomberg. DealReporter had suggested Roche was barreling toward a buyout offer for the California company, including seeking out $15 billion in funding to back its move. Roche CEO Severin Schwan played coy on the takeover talk, but said his company does not "have a need" to raise capital....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.